Cargando…
Ubc9 expression predicts chemoresistance in breast cancer
Ubiquitin-conjugating enzyme 9 (Ubc9), the sole conjugating enzyme for sumoylation, regulates protein function and plays an important role in tumorigenesis. Whether Ubc9 is involved in the chemoresistance of breast cancer remains unknown. In this study, we aimed to evaluate the contribution of Ubc9...
Autores principales: | Chen, Shi-Feng, Gong, Chang, Luo, Ming, Yao, He-Rui, Zeng, Yun-Jie, Su, Feng-Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sun Yat-sen University Cancer Center
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013326/ https://www.ncbi.nlm.nih.gov/pubmed/21880185 http://dx.doi.org/10.5732/cjc.011.10084 |
Ejemplares similares
-
Arabidopsis Ubiquitin-Conjugating Enzymes UBC7, UBC13, and UBC14 Are Required in Plant Responses to Multiple Stress Conditions
por: Feng, Hui, et al.
Publicado: (2020) -
Markers of Tumor-Initiating Cells Predict Chemoresistance in Breast Cancer
por: Gong, Chang, et al.
Publicado: (2010) -
Is Transthyretin a Regulator of Ubc9 SUMOylation?
por: Wieczorek, Elżbieta, et al.
Publicado: (2016) -
Phosphorylation of Ubc9 by Cdk1 Enhances SUMOylation Activity
por: Su, Yee-Fun, et al.
Publicado: (2012) -
Ubc9 Attenuates Myocardial Ischemic Injury Through Accelerating Autophagic Flux
por: Xiao, Qing, et al.
Publicado: (2020)